Novel Theranostics
- Submission status
- Open
- Submission deadline
In recent years, there has been a growing interest in the field of novel theranostics, which encompasses both Positron emission tomography (PET) imaging and radionuclide therapy. Theranostics aims to integrate diagnostic and therapeutic approaches to personalize patient care. PET imaging plays a crucial role in the diagnostics by enabling the visualization and characterization of specific biological targets and pathways relevant to disease pathology. Moreover, PET allows for the evaluation of novel radiotracers designed to target these biological markers, facilitating the development and optimization of targeted therapies.
This collection seeks submissions of original research from researchers and clinicians actively involved in applying PET imaging techniques with novel biological targets and radiotracers, as well as from scientists working on the development of new radiotracers for PET.
Editors
-
Anne M Landau, PhD
Aarhus University, Denmark
-
Mukesh K Pandey, PhD
Mayo Clinic Rochester, USA
Submitting a paper for consideration
To submit your manuscript for consideration at Scientific Reports as part of this Collection, please follow the steps detailed on this page. On the first page of our online submission system, under “I’m submitting:” select the option “any other article type”. Once logged in you can submit your manuscript to a Collection by selecting “Guest Edited Collection”, under the “Choose the appropriate manuscript type” message, and clicking “Continue”. Then when filling out the manuscript information, select the "Novel Theranostics" Collection from the alphabetical list on the “Springer Nature Subject Category” tab. Authors should express their interest in the Collection in their cover letter.
Accepted papers are published on a rolling basis as soon as they are ready.
In addition to papers on Novel Theranostics, Scientific Reports welcomes all original research in the field of Medical Research. To browse our latest articles in Medical Research click here.
